BTIG Maintains Buy on Shoulder Innovations, Raises Price Target to $27
BTIG analyst Ryan Zimmerman maintains Shoulder Innovations (NYSE:SI) with a Buy and raises the price target from $26 to $27.
Stocks · News reference
Transcript: Shoulder Innovations Q2 2026 Earnings Conference Call
On Thursday, Shoulder Innovations (NYSE:SI) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — SHOULDER INNOVATIONS, INC. (SI)
Filed: 2026-10-08 AccNo: 0001699350-26-000058 Size: 159 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Shoulder Innovations Receives FDA Clearance For Its N-22 Humeral Head
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market,